Advisor
CurrentUnlearn helps biopharma companies develop drugs more ethically and efficiently by leveraging generative machine learning models to reduce the number of patients required for placebo controls in clinical trials. We enable clinical trials that are twice as fast, require fewer patients, produce better evidence about therapeutic efficacy, and in which fewer.